These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10875546

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats.
    Sellers DJ, Chess-Williams R.
    J Auton Pharmacol; 2000 Feb; 20(1):15-22. PubMed ID: 11048957
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
    Huang Q, Liu Q, Ouyang D.
    Med Chem; 2019 Feb; 15(1):3-7. PubMed ID: 29792152
    [Abstract] [Full Text] [Related]

  • 5. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM, Steffes MW, Azar S, Brown DM.
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of diabetes on beta-adrenoceptor mediated responsiveness of human and rat atria.
    Dinçer UD, Onay A, Ari N, Ozçelikay AT, Altan VM.
    Diabetes Res Clin Pract; 1998 May; 40(2):113-22. PubMed ID: 9681276
    [Abstract] [Full Text] [Related]

  • 8. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP, Dimitriadis E, Allen T, Dunlop ME, Cooper M, Larkins RG.
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG, Fathallah L.
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [Abstract] [Full Text] [Related]

  • 10. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
    McCormack AJ, Hak LJ, Finn WF.
    Ren Fail; 1991 May; 13(4):267-74. PubMed ID: 1780495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E, Edelist T, Varagiannis E.
    Pharmacology; 1986 May; 32(1):52-60. PubMed ID: 3080763
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.